New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032.
Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY 10032.
Mil Med. 2020 Jun 8;185(5-6):e557-e564. doi: 10.1093/milmed/usz444.
Equine-assisted therapy (EAT) for post-traumatic stress disorder (PTSD) has attracted great interest despite lacking empirical support, a manual, and a standardized protocol. Our team of experts in EAT and PTSD developed an eight-session group EAT treatment protocol for PTSD (EAT-PTSD) and administered it to two pilot groups of military veterans to assess initial effects.
We describe the development of the treatment manual, which was used with two pilot groups of veterans. Protocol safety, feasibility, and acceptability were assessed by reported adverse events, treatment completion rates, and self-rated patient satisfaction. Preliminary data on PTSD, depressive, and anxiety symptoms and quality of life were collected pretreatment, midpoint, post-treatment, and at 3-month follow up.
No adverse events were recorded. All patients completed treatment, reporting high satisfaction. Preliminary data showed decreases in clinician-assessed PTSD and depressive symptoms from pre to post-treatment and follow-up (medium to large effect sizes, d = .54-1.8), with similar trends across self-report measures (d = 0.72-1.6). In our pilot sample, treatment response and remission varied; all patients showed some benefit post-treatment, but gains did not persist at follow-up.
This article presents the first standardized EAT protocol. Highly preliminary results suggest our new manualized group EAT-PTSD appears safe, well-regarded, and well-attended, yielding short-term benefits in symptomatology and quality of life if unclear length of effect. Future research should test this alternative treatment for PTSD more rigorously.
尽管缺乏实证支持、手册和标准化方案,马辅助治疗(EAT)治疗创伤后应激障碍(PTSD)仍引起了极大的关注。我们的 EAT 和 PTSD 专家团队为 PTSD 开发了一个八节团体 EAT 治疗方案(EAT-PTSD),并对两组军事退伍军人进行了试点,以评估初步效果。
我们描述了治疗手册的开发,该手册用于两组退伍军人试点。通过报告的不良事件、治疗完成率和患者自我评估满意度来评估方案的安全性、可行性和可接受性。在治疗前、中点、治疗后和 3 个月随访时收集 PTSD、抑郁和焦虑症状及生活质量的初步数据。
未记录到不良事件。所有患者均完成了治疗,报告满意度高。初步数据显示,从治疗前到治疗后和随访时,临床医生评估的 PTSD 和抑郁症状均有所下降(中等至较大效应量,d=0.54-1.8),自我报告测量也有类似趋势(d=0.72-1.6)。在我们的试点样本中,治疗反应和缓解情况有所不同;所有患者在治疗后都表现出一定的受益,但在随访时获益并未持续。
本文介绍了第一个标准化的 EAT 方案。初步结果表明,我们新的团体 EAT-PTSD 手册似乎安全、受欢迎且参与度高,如果效果持续时间不明确,可在短期内改善症状和生活质量。未来的研究应该更严格地测试这种 PTSD 的替代治疗方法。